IRCT20161204031229N4
Recruiting
Phase 2
Evaluating the effects of oral Selenium as a adjuvant therapy on controling clinical symptoms in rhumatoid arthritis Patients
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Iran University of Medical Sciences
- Enrollment
- 70
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Active disease at the time of enrollment
- •Stable renal function
- •No liver dysfunction
- •Ability to receive oral medication
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Evaluation of the effect of oral selenium administration on tremor reduction of ParkinsoniansTremor.Parkinson diseaseIRCT201101155612N1Yazd University of Medical Sciences26
Not yet recruiting
Not Applicable
Efficacy of oral selenium in treatment of sepsis in preterm neonatesHealth Condition 1: P369- Bacterial sepsis of newborn, unspecifiedCTRI/2024/07/070140Dr. DUMNE SWANEEK JAYANT
Recruiting
Phase 2
Evaluation of the effect of selenium on patients with thyroid cancer treated with radioactive iodineThyroid cancer.Neoplasm of uncertain behavior of thyroid glandD44.0IRCT20201129049534N6Esfahan University of Medical Sciences60
Recruiting
Phase 3
The effect of selenium on cancer related-fatigueCancer-related fatigue.Neoplasm-related fatigueR53.0IRCT20210825052293N1Esfahan University of Medical Sciences70
Completed
Phase 3
Determining the effect of Selenium supplementation on CD4+ T lymphocyte count in HIV+ patients refered to Iranian HIV/AIDS Research Center (IRCHA)HIV infection.Unspecified human immunodeficiency virus [HIV] diseaseIRCT138904244380N2Vice Chancellor For Research, Tehran University of Medical Sciences100